Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
SURPASS-CVOT Looks Beyond the Heart: Tirzepatide Signals Benefits in Infection Mortality, Patient-Reported Outcomes
Ähnliche Seiten
Type 1 Diabetes Overall, Type 2 Diabetes in Kids on the Rise
https://www.medscape.com/viewarticle/type-1-diabetes-overall-type-2-diabetes-kids-rise-2026a10010dqRetatrutide Yields Significant Weight Loss in T2D
https://www.medscape.com/viewarticle/retatrutide-yields-significant-weight-loss-t2d-2026a10010n0Orforglipron Noninferior for CV Outcomes in T2D
https://www.medscape.com/viewarticle/orforglipron-noninferior-insulin-glargine-cardiovascular-2026a10010srGIP/GLP-1 Ups Beta-Cell Function, Insulin Sensitivity in T2D
https://www.medscape.com/viewarticle/tirzepatide-ups-beta-cell-function-insulin-sensitivity-early-2026a10010fkEmployment Status Tied to Heart-Protective Drug Use in T2D
https://www.medscape.com/viewarticle/employment-status-tied-heart-protective-drug-use-type-2-2026a10010bo